31 related articles for article (PubMed ID: 15447739)
1. Non-imidazole histamine H
Guryn R; Staszewski M; Walczyński K
Med Chem Res; 2013 Aug; 22(8):3640-3652. PubMed ID: 23807824
[TBL] [Abstract][Full Text] [Related]
2. Histaminergic regulation of food intake.
Khouma A; Moeini MM; Plamondon J; Richard D; Caron A; Michael NJ
Front Endocrinol (Lausanne); 2023; 14():1202089. PubMed ID: 37448468
[TBL] [Abstract][Full Text] [Related]
3. The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way.
Xu L; Lin W; Zheng Y; Wang Y; Chen Z
Curr Neuropharmacol; 2024; 22(2):241-259. PubMed ID: 36424776
[TBL] [Abstract][Full Text] [Related]
4. KSK-74: Dual Histamine H
Mika K; Szafarz M; Zadrożna M; Nowak B; Bednarski M; Szczepańska K; Pociecha K; Kubacka M; Nicosia N; Juda I; Kieć-Kononowicz K; Kotańska M
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806019
[TBL] [Abstract][Full Text] [Related]
5. Histamine H
Mika K; Szafarz M; Bednarski M; Latacz G; Sudoł S; Handzlik J; Pociecha K; Knutelska J; Nicosia N; Szczepańska K; Kuder KJ; Kieć-Kononowicz K; Kotańska M
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832862
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies with histamine H3-receptor ligands.
Ganellin CR; Fkyerat A; Hosseini SK; Khalaf YS; Piripitsi A; Tertiuk W; Arrang JM; Garbarg M; Ligneau X; Schwartz JC
J Pharm Belg; 1995; 50(2-3):179-87. PubMed ID: 7674117
[TBL] [Abstract][Full Text] [Related]
7. Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist.
Hancock AA; Bennani YL; Bush EN; Esbenshade TA; Faghih R; Fox GB; Jacobson P; Knourek-Segel V; Krueger KM; Nuss ME; Pan JB; Shapiro R; Witte DG; Yao BB
Eur J Pharmacol; 2004 Mar; 487(1-3):183-97. PubMed ID: 15033391
[TBL] [Abstract][Full Text] [Related]
8. Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy.
Hancock AA; Diehl MS; Fey TA; Bush EN; Faghih R; Miller TR; Krueger KM; Pratt JK; Cowart MD; Dickinson RW; Shapiro R; Knourek-Segel VE; Droz BA; McDowell CA; Krishna G; Brune ME; Esbenshade TA; Jacobson PB
Inflamm Res; 2005 Apr; 54 Suppl 1():S27-9. PubMed ID: 15928821
[No Abstract] [Full Text] [Related]
9. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
12. In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists.
Hancock AA; Diehl MS; Faghih R; Bush EN; Krueger KM; Krishna G; Miller TR; Wilcox DM; Nguyen P; Pratt JK; Cowart MD; Esbenshade TA; Jacobson PB
Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):144-52. PubMed ID: 15447739
[TBL] [Abstract][Full Text] [Related]
13. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
